• Keine Ergebnisse gefunden

Supplemental Figure 2. SARS-CoV-2 testing participation rates among SSD school staff over 24 weeks of study.

N/A
N/A
Info
Herunterladen
Protected

Academic year: 2022

Aktie "Supplemental Figure 2. SARS-CoV-2 testing participation rates among SSD school staff over 24 weeks of study."

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Jetzt herunterladen ( 1 Seite )

Volltext

(1)

Supplemental Figure 2. SARS-CoV-2 testing participation rates among SSD school staff over 24 weeks of study.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 0

10 20 30 40 50 60 70 80 90 100

% of All Staff Tested Per Week % of Participants Tested Per Week Week

%

Shown are percentages of consented staff and students who were tested for SARS-CoV-2 each week and the percentage of all staff at the 6 participating SSD schools tested each week. Note: a snowstorm during week 11 impacted testing.

Referenzen

Jetzt herunterladen ( DOCX - 1 Seite - 16.78 KB )

ÄHNLICHE DOKUMENTE

Supplemental Figure 3. Total number of SARS-CoV-2 saliva tests performed per week as part of the study.

[r]

Supplemental Table 1: Study participation and testing by week

[r]

Transmission dynamics of novel coronavirus SARS-CoV-2 among healthcare workers, a case study in Iran

In the fourth step, the authors discover how recruitment of new nurses and doctors impacts the spread of coronavirus among the health- care worker during COVID-19 pandemic..

SARS-CoV-2-Arbeitsschutzstandard

Das in Abschnitt II beschriebene Konzept umfasst zusätzliche und zeitlich befristete Maßnahmen des betrieblichen Arbeitsschutzes als Voraussetzung für einen

Accuracy of serological testing for SARS-CoV-2 antibodies: first results of a large mixed-method evaluation study.

Individual IgG and IgM antibody responses grey dots against RBD c and N protein d in sera of 54 COVID-19 positive and 6 COVID-19 negative individuals as measured by ELISA are

SARS-CoV-2 nanobodies 2.0.

only the different binding epitope residues, but also to predict their competing epitopes with the ACE2 receptor and compare the four nanobodies to other already published

SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland.

Abstract: As pregnant women are at high risk of severe SARS-CoV-2 infection and COVID-19 vaccines are available in Switzerland, this study aimed to assess the willingness of

Reinfektion mit SARS-CoV-2?

Fazit: Auch nach durchgemachter SARS-CoV-2- Infektion (COVID-19) kann es nach ausreichend langer Zeit zu einer erneuten Infektion mit ei- ner Variante des Virus kommen..